Alstroemeria Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 28 Days
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -9491.09%
- Ebitda -9423.41%
- Net Worth -94.92%
- Total Assets 20.94%
About Alstroemeria Healthcare
Alstroemeria Healthcare Private Limited (AHPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 16 January 2019 (Six years 28 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Abu Laskar, Sameer Jha, and Nozmul Choudhury serve as directors at the Company.
Company Details
-
Location
Kamrup, Assam, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999AS2019PTC018981
-
Company No.
018981
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Jan 2019
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Alstroemeria Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abu Laskar
|
Director | 16-Jan-2019 | Current |
|
Sameer Jha
|
Director | 16-Jan-2019 | Current |
|
Nozmul Choudhury
|
Director | 16-Jan-2019 | Current |
Financial Performance of Alstroemeria Healthcare.
Alstroemeria Healthcare Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 9491.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 94.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alstroemeria Healthcare?
Unlock access to Alstroemeria Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Danoma Pharmaceuticals Private LimitedNozmul Choudhury is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alstroemeria Healthcare?
Unlock and access historical data on people associated with Alstroemeria Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alstroemeria Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alstroemeria Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
